Mucopolysaccharidosis Type I
7 clinical trials · Condition
◉ Watch Mucopolysaccharidosis Type I
| Record | Firm | Date |
|---|---|---|
| MRS to Determine Neuroinflammation and Oxidative Stress in MPS I (NCT03576729) | University of Minnesota | 2018-11-01 |
| Biomarker for Hurler Disease (BioHurler) (NCT02298712) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III (NCT03161171) | University Hospital Heidelberg | 2017-07-06 |
| Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI (NCT02437253) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2015-05-01 |
| Longitudinal Studies of Brain Structure and Function in MPS Disorders (NCT01870375) | University of Minnesota | 2009-09-01 |
Track Mucopolysaccharidosis Type I automatically
Every clearance here is in the API, with alerts when new ones post.